Case Study 7: Transporters Case Studies-In Vitro Solutions for Translatable Outcomes

Area of Science:

• Pharmacology
• Drug Metabolism and Pharmacokinetics
• Biochemistry

Background:

• Assessing drug candidate interactions with clinically relevant transporters (e.g., for FDA/EMA submissions) is complex.
• Drug transporters often exhibit broad and overlapping specificities, leading to non-specific interactions.
• Limited availability of specific substrates/inhibitors and clinically relevant probes complicates transporter function evaluation.

Purpose of the Study:

• To highlight the complexities in evaluating drug-transporter interactions.
• To emphasize the importance of selecting appropriate in vitro test systems and probe substrates.
• To illustrate the interpretation of in vitro data for both efflux and uptake transporters.

Main Methods:

• Review and interpretation of in vitro data from various test systems.
• Utilizing multiple probe substrates and test systems for comprehensive transporter evaluation.
• Analysis of transporter kinetics to understand drug interactions.

Main Results:

• Drug transporters often interact with compounds in a non-specific manner.
• Multiple test systems and probes may be necessary for robust assessment.
• Successful interpretation of in vitro data can inform the need for clinical drug interaction studies.

Conclusions:

• Careful selection and nuanced understanding of in vitro tools are essential for accurate drug-transporter interaction assessment.
• Interpreting transporter kinetics is key to predicting potential clinical drug interactions.
• Optimizing in vitro experimental design is critical for regulatory submissions and drug development.